CORRECTING and REPLACING The Law Firm of Levi & Korsinsky, LLP:
December 21 2010 - 11:08AM
Business Wire
First graph, second sentence should read: Under the terms of the
transaction, Martek stockholders will receive $31.50 in cash for
each outstanding share of Martek stock they own for a total
transaction value of approximately $1.09 billion. (sted Under the
terms of the transaction, DSM stockholders will receive $31.50 in
cash for each outstanding share of DSM stock they own for a total
transaction value of approximately $1.09 billion.)
The corrected release reads:
THE LAW FIRM OF LEVI & KORSINSKY, LLP
LAUNCHES AN INVESTIGATION INTO THE POSSIBLE BREACHES OF FIDUCIARY
DUTY BY THE BOARD OF MARTEK BIOSCIENCES CORPORATION IN
CONNECTION WITH THE SALE OF THE COMPANY TO ROYAL DSM N.V. –
MATK
Levi & Korsinsky is investigating the Board of Directors of
Martek Biosciences Corporation (“Martek” or the “Company”)
(NasdaqGS: MATK) for possible breaches of fiduciary duty and other
violations of state law in connection with their attempt to sell
the Company to Royal DSM N.V. (“DSM”) (NYSE: DSM). Under the terms
of the transaction, Martek stockholders will receive $31.50 in cash
for each outstanding share of Martek stock they own for a total
transaction value of approximately $1.09 billion.
Click here to learn how to join the action:
http://www.zlk.com/martek-matk.html, or call: 877-363-5972.
The investigation concerns whether the Martek Board of Directors
breached their fiduciary duties to Martek stockholders by failing
to adequately shop the Company before entering into this
transaction and whether DSM is underpaying for Martek shares, thus
unlawfully harming Martek stockholders.
If you own common stock in Martek and wish to obtain additional
information, please contact Joseph E. Levi, Esq. either via email
at jlevi@zlk.com or by telephone at (212) 363-7500, toll-free:
(877) 363-5972, or visit http://www.zlk.com/martek-matk.html.
Levi & Korsinsky has expertise in prosecuting investor
securities litigation and extensive experience in actions involving
financial fraud and represents investors throughout the nation,
concentrating its practice in securities and shareholder
litigation. The attorneys at Levi & Korsinsky have been
appointed by numerous courts throughout the country to serve as
lead counsel on behalf of shareholders in major litigations
involving mergers and acquisitions. For more information, please
feel free to contact any of the attorneys listed below. Attorney
advertising. Prior results do not guarantee similar outcomes.
Martek (NASDAQ:MATK)
Historical Stock Chart
From Jun 2024 to Jul 2024
Martek (NASDAQ:MATK)
Historical Stock Chart
From Jul 2023 to Jul 2024
Real-Time news about Martek Biosciences Corp. (MM) (NASDAQ): 0 recent articles
More Levi & Korsinsky, LLP News Articles